HOUSE_OVERSIGHT_024757.jpg
1.45 MB
Extraction Summary
0
People
13
Organizations
3
Locations
1
Events
2
Relationships
2
Quotes
Document Information
Type:
Financial report page
File Size:
1.45 MB
Summary
This page from an Ackrell Capital report details capital raised by publicly traded cannabis companies for the year ending September 30, 2017, highlighting that Canadian companies raised significantly more capital than those in the U.S. or Australia. It also provides an overview of the U.S. public capital markets for cannabis, noting that while a few trade on major exchanges like Nasdaq and NYSE, the vast majority are "penny" stocks on the OTC market characterized by high risk and regulatory scrutiny from the SEC and FINRA.
Organizations (13)
Timeline (1 events)
$317 million financing completed by GW Pharmaceuticals in December 2017
Locations (3)
| Location | Context |
|---|---|
Relationships (2)
Key Quotes (2)
"Most of the companies trading on the OTC (i) are “penny” stocks that trade at less than $5.00 per share"Source
HOUSE_OVERSIGHT_024757.jpg
Quote #1
"The U.S. Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA) have historically expressed concerns regarding the “penny” stock industry"Source
HOUSE_OVERSIGHT_024757.jpg
Quote #2
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document